Evogene Ltd. (TLV:EVGN)

Evogene Revenue

In the year 2025, Evogene had annual revenue of $3.85M USD, down -54.73%. Evogene had revenue of $314.00K in the quarter ending December 31, 2025, a decrease of -79.65%.

• Revenue (ttm): $3.95M
• Revenue Growth: -51.39%
• P/S Ratio: 1.88
• Revenue / Employee: $33.79K
• Employees: 117
• Market Cap: 23.03M ILS

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	3.85M	-4.66M	-54.73%
Dec 31, 2024	8.51M	2.87M	50.90%
Dec 31, 2023	5.64M	3.97M	236.72%
Dec 31, 2022	1.68M	745.00K	80.11%
Dec 31, 2021	930.00K	-110.00K	-10.58%
Dec 31, 2020	1.04M	287.00K	38.11%
Dec 31, 2019	753.00K	-994.00K	-56.90%
Dec 31, 2018	1.75M	-1.63M	-48.33%
Dec 31, 2017	3.38M	-3.16M	-48.30%
Dec 31, 2016	6.54M	-4.59M	-41.23%
Dec 31, 2015	11.13M	-3.38M	-23.31%
Dec 31, 2014	14.51M	-3.07M	-17.46%
Dec 31, 2013	17.58M	509.00K	2.98%
Dec 31, 2012	17.07M	2.17M	14.57%
Dec 31, 2011	14.90M	2.34M	18.61%
Dec 31, 2010	12.56M	-	-